We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

Industry Insight

A Decade of Innovation in DNA Polymerase Technology

The Thermo Scientific Phusion High-Fidelity DNA Polymerases are currently celebrating their 10 year anniversary. I used this opportunity to catch up with Thermo Fisher Scientific to learn more about these high-fidelity DNA polymerases.
Industry Insight

Pittcon 2013 Informatics Wrap-Up

What a difference a city makes! Philadelphia turned out to be an excellent venue for Pittcon 2013.
Industry Insight

Microfluidics in Life Science: Moving Forward by Looking Back

Industry Insight

Laboratory Informatics; Climbing the Slope of Enlightenment?

Industry Insight

Screening Together:The Benefits of Academia-industrial Collaborations

Industry Insight

Laboratory Informatics; Climbing the Slope of Enlightenment?

During the recent Electronic Lab Automation 2013 (ELA 2013) conference in Hamburg, Germany, Technology Network's Informatics Editor Helen Gillespie sat down with John Trigg, Director of PhaseFour Informatics, to discuss the integrated lab.
Industry Insight

Global Chemical Safety Issues Scrutinized during Insightful Helsinki Chemicals Forum 2013

Scientists know that while the end-products they develop need to be safe for use, often the research and development path is not.
Industry Insight

The Evolution of the Integrated Platform: Accelrys' One-Two Punch

A look at how Accelrys is delivering an integrated platform of enterprise laboratory solutions.
Industry Insight

The Evolving Relationship of LIMS and Mobile Devices

An Interview with Abbott's Clive Baron about the new STARLIMS Version 11 and how it will leverage mobile devices
Industry Insight

What Makes Good Commercial Antibodies

With the increasing market demand of antibodies and largely commercial availability, quality control is drawing extensive attentions. On one hand, investigators must be aware of potential pitfalls and the specificity of each antibody.
Advertisement